参考文献/References:
[1] 雷晓溪,鄢秀菊,刘苏,等. 孕酮对缺血再灌注视网膜caspase-3、bax表达的影响[J]. 中国医药指南期刊,2011,9(36): 63-64.
[2] 张民,李秀娟,徐思羽,等. 血塞通注射液与常用抗菌药物配伍的稳定性考察[J]. 西部中医药期刊,2018,31(8): 7-10.
[3] 周光姣. 注射用红旱莲总黄酮的制备工艺和质量标准研究[D]. 安徽中医学院,2006.
[4] 孙逊. 天然多羟基酚类化合物Pallidol的全合成和Baicalein的结构改造[D]. 上海: 复旦大学,2004.
[5] 丁锐,纪宏,陈思,等. 注射用前列地尔水分测定方法的建立[J]. 中国药业,2010,19(13): 42-43.
[6] 张捷,尹良军,张书华,等. 费休氏水分测定法测定小柴胡颗粒水分[J]. 延安大学学报(医学科学版),2015,13(3): 6-7.
相似文献/References:
[1]刘冠萍 吕林艳 罗 艳 张木兰 韦日伟.注射用血栓通(冻干)与盐酸克林霉素注射液 配伍的毒性和含量研究[J].大众科技,2018,20(11):26.
Toxicity and Contents of Components in the Compatibility of Lyophilized Xueshuantong for Injection and Clindamycin Hydrochloride Injection[J].Popular Science & Technology,2018,20(10):26.
[2]陈苑君 童冰妮 麦志雄 冼卫清.注射用血栓通(冻干)包装系统密封性研究[J].大众科技,2023,25(9):30.
Study on Sealability of Packaging System of Xueshuantong (Lyophilized) for Injection[J].Popular Science & Technology,2023,25(10):30.
[3]罗 艳,刘冠萍.注射用血栓通(冻干)在脑血管疾病的临床运用进展[J].大众科技,2019,21(05):78.
Advances in the Clinical Application of Xueshuantong for Injection(Lyophilized)in Cerebrovascular Diseases[J].Popular Science & Technology,2019,21(10):78.
[4]覃济桓 张兆佳 王海燕 刘冠萍 梁云飞.气相色谱法测定注射用血栓通(冻干)中 两种成分的残留[J].大众科技,2020,22(08):45.
Determination of Residual Amounts of Two Compounds in Xueshuantong for Injection(Lyophilized) by Gas Chromatography[J].Popular Science & Technology,2020,22(10):45.
[5]黄展文 覃济桓 王海燕 梁云飞 张兆佳.HPLC 法测定注射用血栓通(冻干)中抗氧剂 1010 的迁移含量[J].大众科技,2020,22(09):49.
Determination of Migration Content of Antioxidant 1010 in Xueshuantong for Injection (lyophilized) by HPLC[J].Popular Science & Technology,2020,22(10):49.
[6]张兆佳 梁云飞 黄展文.HPLC法测定注射用血栓通(冻干)中可提取硫的迁移含量[J].大众科技,2021,23(4):51.
Determination of Migration Content of Extractable Sulphur in Xueshuantong for Injection (lyophilized) by HPLC[J].Popular Science & Technology,2021,23(10):51.
[7]蒋腾川 招丽君 兰 星 梁云飞 邓慧芳 黎雅芝.注射用血栓通(冻干)与注射用七叶皂苷钠的配伍稳定性研究[J].大众科技,2021,23(7):25.
Study on Compatibility Stability of Xueshuantong for Injection (lyophilized) andSodium Aescinate for Injection[J].Popular Science & Technology,2021,23(10):25.